Ausgabe 1/2016
Inhalt (12 Artikel)
The Insulin:Glucagon Ratio and the Choice of Glucose-Lowering Drugs
Sanjay Kalra, Yashdeep Gupta
Vitamin D and Diabetic Complications: True or False Prophet?
Uazman Alam, Vilashini Arul-Devah, Saad Javed, Rayaz A. Malik
A Network Meta-analysis Comparing Exenatide Once Weekly with Other GLP-1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus
Sheena Kayaniyil, Greta Lozano-Ortega, Heather A. Bennett, Kristina Johnsson, Alka Shaunik, Susan Grandy, Bernt Kartman
Hypoglycemia Event Rates: A Comparison Between Real-World Data and Randomized Controlled Trial Populations in Insulin-Treated Diabetes
Lisa Elliott, Carrie Fidler, Andrea Ditchfield, Trine Stissing
Diabetes Pharmacotherapies and Bladder Cancer: A Medicare Epidemiologic Study
Todd A. Mackenzie, Rebecca Zaha, Jeremy Smith, Margaret R. Karagas, Nancy E. Morden
The Economic Burden of Post-prandial Hyperglycemia (PPH) Among People with Type 1 and Type 2 Diabetes in Three Countries
Meryl Brod, Annie Nikolajsen, James Weatherall, Kathryn M. Pfeiffer
Transitions of Care for People with Type 2 Diabetes: Utilization of Antihyperglycemic Agents Pre- and Post-Hospitalization
Leslie Montejano, Lien Vo, Donna McMorrow
Non-Persistence and Non-Adherence of Patients with Type 2 Diabetes Mellitus in Therapy with GLP-1 Receptor Agonists: A Retrospective Analysis
Thomas Wilke, Sabrina Mueller, Antje Groth, Bjoern Berg, Andreas Fuchs, Mirko Sikirica, John Logie, Alan Martin, Ulf Maywald
Effect of the SGLT2 Inhibitor Dapagliflozin on Potassium Levels in Patients with Type 2 Diabetes Mellitus: A Pooled Analysis
Yshai Yavin, Traci A. Mansfield, Agata Ptaszynska, Kristina Johnsson, Shamik Parikh, Eva Johnsson
Cystatin C- and Creatinine-Based Estimates of Glomerular Filtration Rate in Dapagliflozin Phase 3 Clinical Trials
Christian Mende, Arie Katz
Peer-to-Peer, Interactive GP Education can Reduce Barriers to Best Practice in Diabetes Management
Gary Deed, Gary Kilov, Patrick Phillips, Anita Sharma, Stephen Leow, Ian Arthur, John Barlow, Mark Kennedy
Faulty Injection Technique: A Preventable But Often Overlooked Factor in Insulin Allergy
Partha Pratim Chakraborty, Sugata Narayan Biswas, Shinjan Patra